CSIR-IICT, Suven Pharma ink MoU for covid drugs Molnupiravir, 2-DG
The antiviral drug initially developed to treat influenza is repurposed to suppress the Covid virus transmission within 24 hours, completely.
Stay updated with breaking news from 2 Dg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The antiviral drug initially developed to treat influenza is repurposed to suppress the Covid virus transmission within 24 hours, completely.
According to the EoI document, applications should be submitted before June 17 through email. "The EoI submitted by industries will be scrutinised by a Technical Assessment Committee (TAC). Only up to 15 industries will be given ToT on their capabilities, technical hand holding capability of DRDO and on First Come First Served Basis," it said.
The 2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr. Reddy’s Laboratories.
Lee Pharma to file application for getting DCGI approval
Requirements for the bidders include a drug license to manufacture Active Pharmaceutical Ingredient (API) from Drug Licensing Authorities and WHO GMP (Good Manufacturing Practices) certification